For example, most of the up-regulated IAGs in GBMO-1201 belong to secretome and IFN/IL classes, suggesting it may persistently release immune molecules into the TME like CCL2, a chemoattract associated with poor prognosis in GBM. The gene discussed is CCL2; the disease is glioblastoma.